anti-inflammation, anti-cancer and hepatoprotection. However, the pharmacological mechanism of andrographolide remains unclear. Therefore, further characterization on the kinetics and molecular targets of andrographolide is essential. In this study, we described the synthesis and characterization of a novel fluorescent andrographolide derivative (ANDRO-NBD). ANDRO-NBD exhibited a comparable anti-cancer
穿心莲内酯(ANDRO)是存在于药用植物穿心莲中的内酯二
萜类化合物,在亚洲和欧洲临床用于多种人类疾病。
穿心莲内酯的药理活性已得到广泛证明,包括抗炎,抗癌和保肝作用。然而,
穿心莲内酯的药理机制仍不清楚。因此,对
穿心莲内酯的动力学和分子靶标进行进一步表征是必不可少的。在这项研究中,我们描述了新型荧光
穿心莲内酯衍
生物(ANDRO-NBD)的合成和表征。ANDRO-NBD具有与
穿心莲内酯相当的抗癌谱:ANDRO-NBD对各种类型的癌细胞具有细胞毒性,并抑制了黑素瘤细胞的迁移活性。ANDRO-NBD处理诱导热休克蛋白90(Hsp90)的裂解及其客户癌蛋白,v-Src和Bcr-abl的下调。值得注意的是,在我们执行的所有抗癌检测中,ANDRO-NBD均表现出优于
穿心莲内酯的抑制作用。此外,ANDRO-NBD还用作荧光探针来研究
穿心莲内酯的吸收动力学,细胞分布和分子靶标。我们的数据显示,ANDRO-NB